PA9159
/ Palo Alto Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
January 16, 2026
Study on the Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects
(clinicaltrials.gov)
- P1 | N=36 | Completed | Sponsor: Anhui Palo Alto Pharmaceuticals, Inc.
New P1 trial • Allergic Rhinitis • Immunology • Inflammation
January 09, 2026
Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
(clinicaltrials.gov)
- P2 | N=60 | Recruiting | Sponsor: Anhui Palo Alto Pharmaceuticals, Inc.
New P2 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
January 08, 2026
Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
(clinicaltrials.gov)
- P2 | N=30 | Recruiting | Sponsor: Anhui Palo Alto Pharmaceuticals, Inc.
New P2 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 3
Of
3
Go to page
1